Artwork

Content provided by OTC Markets Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OTC Markets Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Sigyn Therapeutics Inc.

10:59
 
Distribuie
 

Manage episode 440615072 series 1342326
Content provided by OTC Markets Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OTC Markets Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Sigyn Therapeutics Inc. (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. Jim Joyce, CEO of Sigyn Therapeutics, joins us to discuss the how his company's development of therapies looks to address conditions that are beyond the reach of drugs. Going into 2025, Sigyn Therapeutics is looking to create therapies to target cancer cells to prep patients beginning chemotherapy. Tune in to learn more!

View Podcast Transcript

  continue reading

296 episoade

Artwork
iconDistribuie
 
Manage episode 440615072 series 1342326
Content provided by OTC Markets Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OTC Markets Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Sigyn Therapeutics Inc. (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. Jim Joyce, CEO of Sigyn Therapeutics, joins us to discuss the how his company's development of therapies looks to address conditions that are beyond the reach of drugs. Going into 2025, Sigyn Therapeutics is looking to create therapies to target cancer cells to prep patients beginning chemotherapy. Tune in to learn more!

View Podcast Transcript

  continue reading

296 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință